|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07D 505/24 | (2006.01) |
| A61K 31/546 | (2006.01) | ||
| C07D 501/50 | (2006.01) |
| (11) | Number of the document | 2917223 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13820853.3 |
| Date of filing the European patent application | 2013-10-29 | |
| (97) | Date of publication of the European application | 2015-09-16 |
| (45) | Date of publication and mention of the grant of the patent | 2019-01-16 |
| (46) | Date of publication of the claims translation | 2019-04-10 |
| (86) | Number | PCT/IB2013/002423 |
| Date | 2013-10-29 |
| (87) | Number | WO 2014/068388 |
| Date | 2014-05-08 |
| (30) | Number | Date | Country code |
| 201261719523 P | 2012-10-29 | US |
| (72) |
LIAO, Xiangmin, US
PEARSON, Neil, David, US
PENDRAK, Israil, US
THALGI, Reema, US
YAMAWAKI, Kenji, JP
YOKOO, Katsuki, JP
SATO, Jun, JP
KUSANO, Hiroki, JP
AOKI, Toshiaki, JP
|
| (73) |
Glaxo Group Limited,
980 Great West Road, Brentford, Middlesex TW8 9GS,
GB
Shionogi & Co., Ltd, 1-8, Doshomachi 3 chome Chuo-Ku, Osaka 541-0045, JP |
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | 2 padėtyje pakeistieji cephem junginiai |
| 2 SUBSTITUTED CEPHEM COMPOUNDS |
| Payment date | Validity (years) | Amount | |
| 2019-10-08 | 7 | 162.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2020-10-29 |